You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paclitaxel

Showing 1 - 25 of 4,607
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • albumin-bound paclitaxel
  • paclitaxel
  • (no location specified)
Mar 31, 2022

Peritoneal Malignant Mesothelioma Trial in Rotterdam (Intraperitoneal Paclitaxel Solution (Ml))

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Intraperitoneal Paclitaxel Solution (Ml)
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jul 7, 2022

NSCLC Trial in Shanghai (Pembrolizumab, Paclitaxel, Nab-paclitaxel)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +4 more
  • Shanghai, China
    Zhongshan Hospital Fudan University
Aug 18, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Advanced Gastric Cancer Trial in China (fruquintinib +paclitaxel, fruquintinib + paclitaxel)

Active, not recruiting
  • Advanced Gastric Cancer
  • fruquintinib +paclitaxel
  • fruquintinib placebo + paclitaxel
  • Hefei, Anhui, China
  • +6 more
Aug 16, 2022

Albumin Binding Paclitaxel Compared With Common Paclitaxel in

Recruiting
  • Breast Cancer
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 24, 2022

HR+/HER2- Breast Cancer Trial (Tucidinostat, nab-paclitaxel)

Not yet recruiting
  • HR+/HER2- Breast Cancer
  • (no location specified)
Nov 21, 2022

Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy

Recruiting
  • Neuropathy Associated With Dysproteinaemias
  • no intervention
  • Tekirdağ, Turkey
    Tekirdag Namik Kemal University
Nov 15, 2022

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel

Recruiting
  • Ovarian Cancer
  • +2 more
  • Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Nov 11, 2022

Breast Carcinoma Trial in Houston (biological, drug, other)

Not yet recruiting
  • Breast Carcinoma
  • eftilagimod alpha
  • +2 more
  • Houston, Texas
    Oncology Consultants
Feb 17, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
  • Albumin-bound Paclitaxel
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Feb 6, 2022

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Stricture Urethra Trial in Cairo (DVIU with paclitaxel injection, DVIU)

Recruiting
  • Stricture Urethra
  • DVIU with paclitaxel injection
  • DVIU
  • Cairo, Egypt
    Mohamed Fawzy Salman
Jan 9, 2023

Neuropathic Pain, Chemo Effect Trial in Frankfurt (Telmisartan tablets)

Recruiting
  • Neuropathic Pain
  • Chemotherapy Effect
  • Telmisartan tablets
  • Frankfurt, Germany
    Department of Haematology/Medical Onkology, University Hospital,
Apr 4, 2022

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Triple-Negative Breast Cancer Trial in Shanghai (Camrelizumab plus Famitinib with/without nab-Palitaxel)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Camrelizumab plus Famitinib with/without nab-Palitaxel
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jan 2, 2023

Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
  • Gemcitabine hydrochloride and albumin binding paclitaxel
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Dec 8, 2022

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable Pancreatic Carcinoma Trial in Duarte

Recruiting
  • Stage III Pancreatic Cancer AJCC v8
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2021

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting
  • Pancreas Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Aug 15, 2022

Tumors Trial in Seoul (abemaciclib+paclitaxel)

Active, not recruiting
  • Tumors
  • Seoul, Korea, Republic of
    Severance Hospital
May 30, 2022

Breast Cancer Trial (Intuzumab, pyrrolidone, nab-paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Intuzumab, pyrrolidone, nab-paclitaxel
  • (no location specified)
Jun 29, 2022